Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Moodys
Fish and Richardson
US Army
Cantor Fitzgerald
Mallinckrodt
Cipla
Covington
Boehringer Ingelheim
Queensland Health

Generated: August 19, 2017

DrugPatentWatch Database Preview

EDECRIN Drug Profile

« Back to Dashboard

What is the patent landscape for Edecrin, and when can generic versions of Edecrin launch?

Edecrin is a drug marketed by Aton and is included in two NDAs.

The generic ingredient in EDECRIN is ethacrynate sodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ethacrynate sodium profile page.

Summary for Tradename: EDECRIN

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list37
Clinical Trials: see list1
Patent Applications: see list213
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EDECRIN at DailyMed

Pharmacology for Tradename: EDECRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
EDECRIN
ethacrynic acid
TABLET;ORAL016092-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Aton
EDECRIN
ethacrynic acid
TABLET;ORAL016092-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Aton
EDECRIN
ethacrynate sodium
INJECTABLE;INJECTION016093-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Teva
Cipla
Citi
Baxter
Moodys
US Army
Daiichi Sankyo
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot